Covered recipient · General Payments record
HOPE B MCLENDON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2025
$5,260.91
- Reported across 183 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $767.01 | 34 |
| Long term medical supply or device loan | $183.03 | 2 |
| Education | $43.25 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $228.45 | 4 |
| BeOne Medicines USA, Inc. | $64.23 | 2 |
| Acerta Pharma LLC | $61.93 | 2 |
| Janssen Biotech, Inc. | $61.03 | 3 |
| GlaxoSmithKline, LLC. | $46.74 | 2 |
| Gilead Sciences, Inc. | $44.33 | 2 |
| Celgene Corporation | $42.26 | 2 |
| PFIZER INC. | $38.95 | 2 |
| Adaptive Biotechnologies Corporation | $35.59 | 2 |
| Legend Biotech USA Inc. | $32.63 | 1 |
| Astellas Pharma US Inc | $29.17 | 1 |
| Stemline Therapeutics Inc. | $29.12 | 1 |
| AVEO Pharmaceuticals, Inc. | $26.73 | 1 |
| EISAI INC. | $25.45 | 1 |
| Daiichi Sankyo Inc. | $24.60 | 1 |
| GENZYME CORPORATION | $24.56 | 1 |
| Exelixis Inc. | $23.18 | 1 |
| Caris MPI, Inc. | $22.94 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.87 | 1 |
| Incyte Corporation | $20.65 | 1 |
| SpringWorks Therapeutics, Inc. | $19.23 | 1 |
| Genentech USA, Inc. | $18.78 | 1 |
| Regeneron Healthcare Solutions, Inc. | $18.02 | 1 |
| Azurity Pharmaceuticals, Inc. | $16.82 | 1 |
| Karyopharm Therapeutics Inc. | $16.03 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (37)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.